Drug intelligence / Profile preview

DEVIT-3

Development stage
Unknown
Lead developer
Deva Pharmaceuticals
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Oral, Intramuscular
01

Overview

DEVIT-3 is a vitamin D3 (cholecalciferol) supplement available in various formulations, including oral drops, oral solution, and intramuscular injection. It's primarily used to treat and prevent vitamin D deficiency, which is essential for healthy bones, muscles, nerves, and immune system function. ## Formulations and Dosage DEVIT-3 comes in several strengths: - 300,000 IU/ml solution for intramuscular injection - 50,000 IU/15ml oral drops The medication is typically administered as directed by a healthcare provider, with dosage based on the patient's medical condition, sun exposure, diet, age, and response to treatment[1][2]. ## Uses and Indications DEVIT-3 is indicated for: - Treatment and prevention of vitamin D deficiency, particularly in patients with gastrointestinal absorption disorders[2] - Prevention and treatment of bone disorders such as rickets (in children) and osteomalacia (in adults)[1][3] - Management of osteoporosis when used with calcium[3] - Support for patients with hypoparathyroidism, pseudohypoparathyroidism, and familial hypophosphatemia[3] - Maintaining normal calcium levels in kidney disease patients[4] ## How It Works Vitamin D3 (cholecalciferol) is synthesized in the skin following sunlight exposure and is then converted in the liver to calcifediol (25-hydroxycholecalciferol), which is further converted in the kidney to calcitriol (1,25-dihydroxycholecalciferol)[6]. This active form promotes calcium absorption in the intestines, helping to maintain proper calcium levels in the blood and supporting bone health[6]. ## Administration For oral formulations: - Take as directed, typically once or twice daily - May be taken with or without food, though it's best absorbed when taken after a meal - For liquid forms, carefully measure the dose using a special measuring device - For children, drops may be added to food or drink[3][4] For injectable formulations: - Administered via intramuscular injection by healthcare professionals[2][5] ## Side Effects and Precautions DEVIT-3 should not be used by patients with: - Hypercalcemia (increased calcium concentration in blood) - Known allergies to cholecalciferol or other ingredients[2] Excessive doses can lead to vitamin D toxicity (hypervitaminosis D), which may cause symptoms such as vomiting, constipation, muscle weakness, and confusion[6]. ## Manufacturer DEVIT-3 is manufactured by DEVA Holding A.Ş., based in Turkey[2][5].

Brand names
DEVIT-3DEVIT3DEVIT 3
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on DEVIT-3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DEVIT-3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call